Trends in Provision of Medications and Lifestyle Counseling in Ambulatory Settings by Gender and Race for Patients With Atherosclerotic Cardiovascular Disease, 2006-2016
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.51156
Abstract: Key Points Question What are the trends and sociodemographic variations in the use of secondary prevention treatments for US adults with atherosclerotic cardiovascular disease (ASCVD) in ambulatory settings prior to and following the 2013 American… read more here.
Keywords: lifestyle counseling; cardiovascular disease; cardiology; ambulatory settings ... See more keywords
Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Cardiology"
DOI: 10.1002/clc.23935
Abstract: Despite the availability of effective therapies that lower low‐density lipoprotein cholesterol (LDL‐C) levels in patients with atherosclerotic cardiovascular disease, many eligible patients are inadequately treated and their LDL‐C levels remain suboptimal. Patient nonadherence to lipid‐lowering… read more here.
Keywords: adherence; patients atherosclerotic; cardiovascular disease; therapy ... See more keywords
Current pharmacotherapies for atherosclerotic cardiovascular diseases
Sign Up to like & getrecommendations! Published in 2019 at "Archives of Pharmacal Research"
DOI: 10.1007/s12272-019-01116-1
Abstract: Despite the introduction of statins for lowering LDL-C level, atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of death and morbidity worldwide. Combination therapies with statin and other lipid-lowering drugs, including ezetimibe and proprotein convertase… read more here.
Keywords: current pharmacotherapies; atherosclerotic cardiovascular; treatment; cardiovascular diseases ... See more keywords
Clinical Impact of Weight-Loss Pharmacotherapy in Patients with Atherosclerotic Cardiovascular Disease
Sign Up to like & getrecommendations! Published in 2020 at "American Journal of Cardiovascular Drugs"
DOI: 10.1007/s40256-020-00428-8
Abstract: Obesity is associated with the development and progression of multiple cardiovascular risk factors, such as hypertension, dyslipidemia, and type 2 diabetes mellitus, and is an important contributor to the global burden of atherosclerotic cardiovascular disease… read more here.
Keywords: atherosclerotic cardiovascular; weight loss; loss pharmacotherapy; cardiovascular disease ... See more keywords
Simulation of impact on cardiovascular events due to lipid-lowering therapy intensification in a population with atherosclerotic cardiovascular disease.
Sign Up to like & getrecommendations! Published in 2019 at "American heart journal"
DOI: 10.1016/j.ahj.2019.06.005
Abstract: In patients with atherosclerotic cardiovascular disease (ASCVD), guidelines recommend statins as first-line lipid-lowering therapy (LLT) with addition of nonstatin agents in those with persistently elevated low-density lipoprotein cholesterol levels. METHODS To estimate the cardiovascular (CV)… read more here.
Keywords: population; intensification; treatment intensification; atherosclerotic cardiovascular ... See more keywords
nCorrelates of SGLT-2-inhibitiors Use Among Patients with Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus: Insights from the Department of Veterans Affairs.
Sign Up to like & getrecommendations! Published in 2021 at "American heart journal"
DOI: 10.1016/j.ahj.2021.12.006
Abstract: This study using data from the Veterans Affairs (VA) administrative and clinical dataset examined determinants of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) use among patients with concomitant atherosclerotic cardiovascular disease (ASCVD) and diabetes mellitus. The aim of… read more here.
Keywords: use among; atherosclerotic cardiovascular; cardiovascular disease; diabetes mellitus ... See more keywords
Familial hypercholesterolemia and atherosclerotic cardiovascular mortality among Korean adults with low levels of serum cholesterol.
Sign Up to like & getrecommendations! Published in 2018 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2018.09.012
Abstract: BACKGROUND AND AIMS A few studies examined association between familial hypercholesterolemia (FH) and atherosclerotic cardiovascular disease (ASCVD) in Asians with low levels of serum cholesterol. The objectives of this study were to estimate the prevalence… read more here.
Keywords: atherosclerotic cardiovascular; hypercholesterolemia atherosclerotic; mortality; familial hypercholesterolemia ... See more keywords
Plasma levels of apolipoproteins C-III, A-IV, and E are independently associated with stable atherosclerotic cardiovascular disease.
Sign Up to like & getrecommendations! Published in 2019 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2018.11.006
Abstract: BACKGROUND AND AIMS Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). As key regulators of lipoprotein metabolism, apolipoproteins (apos) are discussed as vascular risk factors. This study aimed to analyze associations of… read more here.
Keywords: atherosclerotic cardiovascular; plasma; iii independently; disease ... See more keywords
Association between the cumulative exposure to bisphosphonates and hospitalization for atherosclerotic cardiovascular events: A population-based study.
Sign Up to like & getrecommendations! Published in 2020 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2020.03.021
Abstract: BACKGROUND AND AIMS Although bisphosphonates have been suggested to protect against atherosclerotic cardiovascular (CV) events, evidence is still conflicting. We aimed at investigating the effect of bisphosphonates on hospitalizations for atherosclerotic CV events. METHODS We… read more here.
Keywords: atherosclerotic cardiovascular; hospitalization; association cumulative; cardiovascular events ... See more keywords
Harnessing nucleic acid-based therapeutics for atherosclerotic cardiovascular disease: state of the art.
Sign Up to like & getrecommendations! Published in 2019 at "Drug discovery today"
DOI: 10.1016/j.drudis.2019.04.007
Abstract: Dyslipidemia is one of the major but modifiable risk factors for atherosclerotic cardiovascular disease (ACVD). Despite the accessibility of statins and other lipid-lowering drugs, the burden of ACVD is still high globally, highlighting the need… read more here.
Keywords: atherosclerotic cardiovascular; acid based; harnessing nucleic; cardiovascular disease ... See more keywords
The Evolving Epidemiology of Atherosclerotic Cardiovascular Disease in People with Diabetes.
Sign Up to like & getrecommendations! Published in 2018 at "Endocrinology and metabolism clinics of North America"
DOI: 10.1016/j.ecl.2017.11.001
Abstract: Atherosclerotic cardiovascular disease (ASCVD) is a leading global cause of death and accounts for most deaths among individuals with diabetes. This article reviews the latest observational and trial data on changes in the relationship between… read more here.
Keywords: atherosclerotic cardiovascular; epidemiology atherosclerotic; evolving epidemiology; epidemiology ... See more keywords